Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Perifosine, an oral bioactive AKT inhibitor induces in vitro and in vivo antitumor activity in Waldenstroms Macroglobulinemia

Perifosine, an oral bioactive AKT inhibitor induces in vitro and in vivo antitumor activity in Waldenstroms Macroglobulinemia. ASH. 2006.


Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.